Taoka Brandon M, Qi Ning, Brill Zachary G, Donofrio Anthony, Meng Tao, Zheng Yiting, Matsuura Bryan S, Nair Anilkumar G, Merchant Rohan R
Department of Discovery Chemistry, Merck & Co., Inc., South San Francisco, California 94080, United States.
Department of Discovery Chemistry, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
ACS Med Chem Lett. 2025 Jan 28;16(2):336-343. doi: 10.1021/acsmedchemlett.4c00591. eCollection 2025 Feb 13.
From a retrosynthetic standpoint, or heterocyclic cores are fundamental disconnections that chemists make. This manuscript highlights heterocycle synthesis as the strategic bond disconnection by leveraging ubiquitous building blocks, carboxylic acids and amines, for preparation of heterocyclic cores in a library-friendly format. This heterocyclic formation strategy allows medicinal chemists to access much wider chemical space, especially for analogs with higher Fsp vs state-of-the-art heterocycle functionalization methods. The direct impact on medicinal chemistry programs is underscored by adapting and miniaturizing the synthesis of N2-indazoles and C2-benzimidazoles to μ-scale parallel medicinal chemistry (PMC) libraries, affording a similar success rate (80%) as venerable Suzuki and Buchwald-Hartwig libraries.
从逆合成的角度来看,杂环核心是化学家进行的基本切断。本手稿强调了杂环合成是一种战略键切断方法,通过利用普遍存在的构建块——羧酸和胺,以适合文库的形式制备杂环核心。这种杂环形成策略使药物化学家能够进入更广阔的化学空间,特别是对于与现有杂环官能化方法相比具有更高Fsp的类似物。通过将N2-吲唑和C2-苯并咪唑的合成进行调整并缩微至μ规模的平行药物化学(PMC)文库,突出了对药物化学项目的直接影响,其成功率与著名的铃木和布赫瓦尔德-哈特维希文库相似(80%)。